TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Connecticut Investigators

Richard C. Frank, MD

Norwalk Hospital


Norwalk, Connecticut - 06856 (203-852-2996)
  • CLINICAL TRIALS 11
  • CONDITIONS24
  • INTERVENTIONS39
  • SINCE
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

-
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

May 2009 - December 2012
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

October 2009 - April 2013
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

September 2006 - July 2008
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

November 2008 - August 2011
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia

August 2006 - February 2008
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

December 2006 - September 2011
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402

December 2007 - June 2016
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

August 2003 - July 2010
Breast Neoplasms

Colonic Neoplasms

Adenocarcinoma

Prostatic Neoplasms

Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphoid

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Myelodysplastic Syndromes

Preleukemia

Leukemia, Myelomonocytic, Acute

Leukemia, Myelomonocytic, Chronic

Carcinoma, Renal Cell

Carcinoma

Fatigue

Esophageal Diseases

Esophageal Neoplasms

Colorectal Neoplasms

Sleep Disorders

Carcinoma in Situ

Carcinoma, Intraductal, Noninfiltrating

Carcinoma, Ductal, Breast

Carcinoma, Ductal

Placebo

Laboratory Biomarker Analysis

Assessment Of Therapy Complications

Psychosocial Assessment And Care

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Cyclophosphamide

Radiation Therapy

Oxaliplatin

Doxorubicin Hydrochloride

Rad001

Polymerase Chain Reaction

Flow Cytometry

Goserelin

Leuprolide Acetate

Triptorelin

Trastuzumab

Western Blotting

Fluorescence In Situ Hybridization

Conventional Surgery

Azacitidine

Mutation Analysis

Sunitinib

Cetuximab

Cognitive Assessment

Tamoxifen Citrate

Irinotecan Hydrochloride

Fatigue Assessment And Management

Nucleic Acid Sequencing

Ac Regimen

Exemestane

Entinostat

Epirubicin Hydrochloride

Oophorectomy

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo